Amsurg Corp Stock Rating Upgraded by SunTrust (AMSG)
Amsurg Corp (NASDAQ:AMSG) was upgraded by SunTrust from a “neutral” rating to a “buy” rating in a research note issued on Friday. The firm currently has a $54.00 price target on the stock, up from their previous price target of $50.00. SunTrust’s price objective points to a potential upside of 17.90% from the company’s current price.
A number of other firms have also recently commented on AMSG. Analysts at Robert W. Baird upgraded shares of Amsurg Corp from a “neutral” rating to an “outperform” rating in a research note on Friday. They now have a $55.00 price target on the stock, up previously from $44.00. Separately, analysts at Raymond James upgraded shares of Amsurg Corp from a “market perform” rating to a “strong-buy” rating in a research note on Friday, May 30th. They now have a $60.00 price target on the stock. Finally, analysts at Deutsche Bank upgraded shares of Amsurg Corp from a “hold” rating to a “buy” rating in a research note on Thursday, May 29th. They now have a $56.00 price target on the stock, up previously from $47.50. Four research analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. The company has a consensus rating of “Buy” and an average price target of $52.75.
Shares of Amsurg Corp (NASDAQ:AMSG) opened at 45.80 on Friday. Amsurg Corp has a 52 week low of $35.06 and a 52 week high of $52.81. The stock’s 50-day moving average is $46.17 and its 200-day moving average is $45.1. The company has a market cap of $1.455 billion and a P/E ratio of 20.36.
Amsurg Corp (NASDAQ:AMSG) last posted its quarterly earnings results on Tuesday, April 22nd. The company reported $0.53 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.55 by $0.02. The company had revenue of $263.11 million for the quarter, compared to the consensus estimate of $272.09 million. During the same quarter in the previous year, the company posted $0.52 earnings per share. The company’s revenue for the quarter was up 1.9% on a year-over-year basis. Analysts expect that Amsurg Corp will post $2.44 EPS for the current fiscal year.
AmSurg Corp. is the owner and operator of short stay ambulatory surgery centers (NASDAQ:AMSG) in the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.